BioInvent International AB (publ) (STO:BINV)
Sweden · Delayed Price · Currency is SEK 4.185
-1.245 (-22.93%)
Nov 2, 2026, 5:24 PM CET
STO:BINV Financials Overview
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 39.98 | 226.5 | 44.69 | 71.46 | 326.13 | 19.38 |
Revenue Growth | -83.67% | 406.86% | -37.47% | -78.09% | 1582.45% | -86.85% |
Gross Profit Gross Profit Growth | 39.98 | 226.5 | 44.69 | 71.46 | 326.13 | 19.38 |
Operating Income Operating Income Growth | -496.24 | -351.28 | -471.25 | -370.56 | -50.47 | -278.17 |
Net Income Net Income Growth | -486.85 | -332.86 | -429.38 | -330.3 | -42.5 | -278.44 |
Earnings Per Share EPS Growth | -7.40 | -5.06 | -6.53 | -5.02 | -0.69 | -5.14 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Sweden Sweden Growth | 2.16 | 13.72 | 3.89 | 18.26 | 25.63 | 13.52 |
Europe Europe Growth | 12.57 | 1.24 | 2.93 | 2.95 | 27.1 | 4.21 |
USA USA Growth | 23.93 | 210.95 | 36.82 | 47.39 | 273.39 | 1.66 |
Other Countries Other Countries Growth | 1.33 | 0.58 | 1.05 | 2.85 | - | - |
Total Total Growth | 39.98 | 226.5 | 44.69 | 71.46 | 326.13 | 19.38 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 224.56 | 592.75 | 867.16 | 1,069 | 1,017 | 1,083 |
Total Debt Total Debt Growth | 19.33 | 8.53 | 17.41 | 23.24 | 26.96 | 28.37 |
Net Cash (Debt) Net Cash Growth | 205.24 | 584.22 | 849.75 | 1,045 | 990.52 | 1,054 |
Net Cash Growth | -69.81% | -31.25% | -18.72% | 5.55% | -6.06% | 46.93% |
Net Cash Per Share Net Cash Per Share Growth | 3.12 | 8.88 | 12.91 | 15.90 | 16.10 | 19.47 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -448.86 | -247.76 | -380.47 | -341.69 | -41.23 | -245.84 |
Capital Expenditures CapEx Growth | -2.71 | -7.26 | -10.03 | -13.3 | -12.38 | -13.26 |
Free Cash Flow Free Cash Flow Growth | -451.58 | -255.02 | -390.5 | -355 | -53.6 | -259.1 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -1241.16% | -155.09% | -1054.58% | -518.54% | -15.48% | -1435.02% |
Pretax Margin | -1216.62% | -146.79% | -960.57% | -461.93% | -13.03% | -1436.46% |
Profit Margin | -1217.66% | -146.96% | -960.87% | -462.22% | -13.03% | -1436.46% |
FCF Margin | -1129.45% | -112.59% | -873.88% | -496.77% | -16.44% | -1336.68% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 3.20 | 6.09 | 0.12 | 0.12 | 0.12 |
PS Ratio | 8.94 | 8.54 | 56.70 | 17.46 | 6.39 | 139.36 |